Temporal relationship of asthma to acute chest syndrome in sickle cell disease
Related Experiment Video
Updated: Jul 18, 2026

Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
Karl P Sylvester1, Richard A Patey, Simon Broughton
1Division of Asthma, Allergy and Lung Biology, King's College London, United Kingdom.
Insights
Asthma exacerbations may trigger acute chest syndrome (ACS) in children with sickle cell disease (SCD). This study found a link between asthma diagnosis and the timing of a child's first ACS episode.
Area of Science:
- Pediatric Hematology
- Pulmonology
- Sickle Cell Disease Research
Background:
- Acute chest syndrome (ACS) is a significant cause of mortality and morbidity in pediatric sickle cell disease (SCD) patients.
- Previous reports suggest a potential association between asthma and ACS, necessitating further investigation.
Purpose of the Study:
- To investigate the prevalence of asthma in children with SCD compared to controls.
- To examine the temporal relationship between asthma diagnosis and the first ACS episode in SCD patients.
Main Methods:
- Prospective recruitment of 165 SCD children and 151 age- and ethnicity-matched controls.
- Data collection included anti-asthma medication use and detailed medical record review for ACS episodes and asthma diagnosis timing in SCD children.
Main Results:
- Similar proportions of SCD children and controls used anti-asthma medication (7% vs. 9%).
- SCD children with ACS were more likely to be taking anti-asthma medication (P = 0.02).
- Children experiencing ACS were diagnosed with asthma a median of 3.5 years before their first ACS episode.
Conclusions:
- Asthma exacerbations may act as a predisposing factor for acute chest syndrome in children with sickle cell disease.
- Findings suggest a potential link between asthma and increased risk of ACS in pediatric SCD patients.
Abstract:
Acute chest syndrome (ACS) is an important cause of mortality and morbidity in children with sickle cell disease (SCD). An association between asthma and ACS has been reported. Our aims were to determine whether asthma was more common in SCD children than controls and the relationship of the timing of the SCD children's first ACS episode to a diagnosis of asthma. One hundred and sixty-five SCD children median age 8.2 (range 0.3-17.3) years and 151 similar ethnic origin and aged controls were prospectively recruited into the study and a detailed history was taken from all of the children to determine if they were taking anti-asthma medication. The medical records of the SCD children were examined to assess whether they had an ACS episode, the age this episode occurred and when any diagnosis of asthma had been made. A similar proportion of the SCD children and controls were taking anti-asthma medication (7% and 9%). Thirty-three SCD children had at least one ACS episode. More of the children who had an ACS compared to those who had not were taking anti-asthma medication (P = 0.02). The ACS children had been diagnosed as asthmatic at a median of 3.5 (range 0.5-7) years prior to their first ACS episode. In conclusion, these results suggest asthma exacerbations may predispose to ACS episodes.
Related Concept Videos
Asthma III: Clinical Manifestations
Asthma I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: